Search clinical trials for: Hair Regrowth

Total 1152 results

Emma Guttman
Pfizer

Completed

Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

Cicatricial Alopecia

United States
Seoul National University Bundang Hospital

Completed

Artificial Intelligence-based Prescription of Personalized Scalp Cosmetics

Folliculitis | Dandruff

Korea, Republic of
Kirby Institute
Monash University; South Australian Health and Medical Research Institute

Active, not recruiting

Impact of the Daily Doxycycline Pre-exposure Prophylaxis (PrEP) on the Incidence of Syphilis, Gonorrhoea and Chlamydia (Syphilaxis)

STIs Prevention

Australia
University of Memphis

Active, not recruiting

Impact of a Topical Cosmetic Product on Women's Hair

Hair Loss | Hair Thinning

United States
Cyprium Therapeutics, Inc.

Enrolling by invitation

Long Term Follow-up on Menkes Disease Patients

Menkes Disease

United States
Indonesia University

Completed

Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

Androgenetic Alopecia

Indonesia
Cutera Inc.

Completed

Ultrasound Device for Hair Removal

Hair Removal
Indonesia University

Active, not recruiting

Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia

Androgenetic Alopecia

Indonesia
Joseph Tuscano
National Cancer Institute (NCI); Celgene

Active, not recruiting

CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma

Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditions

United States
University of Minnesota

Withdrawn

Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia

Androgenetic Alopecia | Male Pattern Baldness | Male Pattern Hair Loss

United States
Pfizer
In Expanded Access, treating physicians are the Sponsors

Available

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Alopecia Areata
Reistone Biopharma Company Limited

Active, not recruiting

Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

Alopecia Areata

China
Pfizer

Completed

A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age

Alopecia Areata

United States
University of Minnesota

Completed

Study on Hypoallergenic Hair Dye

Dermatitis | Contact Dermatitis | Allergy; Dermatitis

United States
Momentum Data
Pfizer; University of Oxford

Active, not recruiting

Healthcare Disparities in Alopecia Areata

Alopecia Areata

United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Cancer

France, Spain, Netherlands, Canada, Austria, United States, Germany, Italy, Japan, Norway, Korea, Republic of, Denmark, Sweden, Belgium
Cooler Heads Care Inc.

Withdrawn

A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads

Breast Cancer | Gynecologic Cancer | Alopecia | Chemotherapy-induced Alopecia | Hair Loss

United States
University of Chicago

Completed

Memantine in Body Focused Repetitive Behaviors

Trichotillomania (Hair-Pulling Disorder) | Dermatillomania

United States
Suzhou Kintor Pharmaceutical Inc,

Completed

Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029

Acne Vulgaris | Androgenetic Alopecia

United States
University of Nebraska
Centers for Disease Control and Prevention

Withdrawn

Clearance of NNAL and Cotinine From Second-hand Smoke in Hair and Urine (NNAL)

Lung Cancer

United States
Alexey Danilov, MD
Gilead Sciences; Oregon Health and Science University

Completed

Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

Anemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Hairy Cell Leukemia | Richter Syndrome | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Grade 1 Follicular... and other conditions

United States
Galderma R&D

Completed

Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia

Male Pattern of Hair Loss, Androgenic Alopecia

United States
Nutraceutical Wellness Inc.

Completed

Nutraceutical Supplement With Vegan Botanicals in Females With Self-Perceived Thinning Hair

Hair Thinning

United States
Galderma R&D

Completed

Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia

Female Pattern Hair Loss, Androgenic Alopecia

United States
Nutraceutical Wellness Inc.

Completed

Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair

Hair Thinning

United States
Cutia Therapeutics（Wuxi）Co.,Ltd

Completed

A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)

AGA

China
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Northwestern University; Northwell Health; Dana-Farber... and other collaborators

Active, not recruiting

BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia

Hairy Cell Leukemia

United States
University of Edinburgh
NHS Lothian; NHS Tayside; NHS Greater Glasgow and Clyde; NHS Lanarkshire

Active, not recruiting

Predicting Endoleaks Following Endovascular Aortic Aneurysm Repair Using 18F-Sodium Fluoride (PET-EVAR)

Abdominal Aortic Aneurysm | Endoleak | Stent-Graft Endoleak

United Kingdom
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-208

Androgenetic Alopecia

Korea, Republic of
Seppic

Completed

Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect

Healthy Volunteers

Italy
Suzhou Kintor Pharmaceutical Inc,

Completed

Phase II Study Evaluating the Efficacy and Safety of KX-826

Androgenetic Alopecia (AGA)

China
Applied Biology, Inc.
Hospital Universitario Ramon y Cajal

Withdrawn

In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity

COVID-19 | SARS-CoV 2 | COVID | Androgenetic Alopecia | Androgen Deficiency | Androgen Receptor Abnormal

Spain
University Hospital, Bordeaux

Completed

Hair Cortisol and Cushing's Disease (HAIRCUSH)

Cushing Disease

France
Farmoquimica S.A.
Kosmoscience Ciência e Tecnologia Cosmética Ltda

Completed

Evaluation of the Efficacy of a New Supplement for Hair and Nails - in Vitro, Clinical, Subjective and Instrumental Study

Nails, Ingrown | Hair Loss

Brazil
Merz Therapeutics GmbH

Completed

Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss

Diffuse Hair Loss in Females

Germany
Pfizer
Arena is a wholly owned subsidiary of Pfizer

Completed

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Alopecia Areata

United States, Canada
University Hospital, Bordeaux

Completed

Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus (ISOLED)

Rheumatoid Arthritis | Lupus Erythematosus | Autoimmune Thrombocytopenia

France
Jinnah Postgraduate Medical Centre

Completed

Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.

Alopecia Areata

Pakistan
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) (THRIVE-AA2)

Alopecia Areata

Spain, United States, Poland, Canada, France, Germany, Hungary
Nanfang Hospital, Southern Medical University

Completed

Evaluation of the Effect of HFMT in Promoting Donor-site Wound Healing

Wound Heal

China
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

Lymphoma | Leukemia

United States
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Investigation of Potential Retinal Toxicity Associated With Hair Dye Products Containing pPD Type Aromatic Amines (CAPITOX)

MEK Inhibitor-Associated Serous Retinopathy

France
Yale University

Completed

Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling

Androgenic Alopecia

United States
Kasr El Aini Hospital

Completed

Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids

Alopecia Areata

Egypt
Combined Military Hospital Abbottabad

Completed

Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata

Alopecia Areata

Pakistan
Westlake University

Completed

Westlake Precision Nutrition Study 2 (WePrecision2) (WePrecision2)

Healthy | Overweight and Obesity

China
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Completed

Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer

Depression | Pain | Fatigue | Sleep Disorder | Anxiety | Breast Carcinoma | Lung Carcinoma | Alopecia | Colorectal Carcinoma | Nausea and Vomiting | Weight Change | Cognitive Side Effects of Cancer Therapy | Psychological Impact of Cancer

United States
Fundacion para la Investigacion Biomedica del Hospital...

Active, not recruiting

Exploratory Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.

Male Androgenetic Alopecia

Spain
NovoBliss Research Pvt Ltd

Completed

Validation and Standardization of Test Methods and Evaluators for Testing of Hair Care Range of Products

Healthy Subject

India
Mehdi Rashighi

Withdrawn

Hair Transplantation for Treatment of Vitiligo

Vitiligo

United States

Search clinical trials for: Hair Regrowth

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations